HONG KONG, June 10, 2015 /PRNewswire/ — Ally Bridge Group (“ABG”), a leading China-global cross-border healthcare-focused investment group – which announced a USD3.3 billion proposed take-private offering for Wuxi Pharmatech (NYSE: WX) on April 30, 2015 – is pleased to announce that it has completed six new investments in medical

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone